Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders

Verolet, Charlotte; Delhumeau-Cartier, Cécile; Sartori, Marlene; Toma, Simona; Zawadynski, Sophie; Becker, Minerva; Bernasconi, Enos; Toutous Trellu, Laurence Marie; Calmy, Alexandra

doi:10.1186/s12981-015-0061-z

Scientific article

English

Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders

ContributorsVerolet, Charlotte; Delhumeau-Cartier, Cécile; Sartori, Marlene; Toma, Simona; Zawadynski, Sophie; Becker, Minerva; Bernasconi, Enos; Toutous Trellu, Laurence Marie; Calmy, Alexandra

Published inAIDS research and therapy, vol. 12, 21

Publication date2015

Abstract

Lipodystrophy (LD) is a frequent adverse event of combination antiretroviral therapy (ART) and occurs mainly in patients exposed to first-generation antiretroviral drugs. The aim of this study was to explore and measure the interaction between LD, mental health, and quality of life of human immunodeficiency virus (HIV) positive individuals seen in a metabolic clinic.

Affiliation entities

Research groups

Groupe Becker Minerva (imagerie ORL) (683)

Citation (ISO format)

VEROLET, Charlotte et al. Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders. In: AIDS research and therapy, 2015, vol. 12, p. 21. doi: 10.1186/s12981-015-0061-z

Article (Published version)

Identifiers

PID : unige:83962
DOI : 10.1186/s12981-015-0061-z
PMID : 26097493

Journal ISSN1742-6405

579views

299downloads

Creation30/05/2016 10:07:00

First validation30/05/2016 10:07:00

Update time15/03/2023 00:22:59

Status update15/03/2023 00:22:59

Last indexation31/10/2024 03:28:51

Archive ouverte UNIGE

Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders

Technical informations